Phase-Tunable Fabrication of Consolidated (α+β)-TiZr Alloys for Biomedical Applications through Molten Salt Electrolysis of Solid Oxides

Junjun Peng, Hualin Chen, Xianbo Jin*, Tao Wang, Dihua Wang and George Z. Chen*
College of Chemistry and Molecular Sciences, Hubei Key Laboratory of Electrochemical Power Sources, Wuhan University, Wuhan,430072, People’s Republic of China
Department of Chemical and Environmental Engineering, Faculty of Engineering, The University of Nottingham, Nottingham, NG7 2RD, United Kingdom
Chem. Mater., 2009, 21 (21), pp 5187–5195
DOI: 10.1021/cm902073g
Publication Date (Web): October 19, 2009
Copyright © 2009 American Chemical Society
*Authors to whom correspondence should be addressed. Tel.: +86 27 68756319 (X.B.J.), +44 (0)115 9514171 (G.Z.C.); Fax: +86 27 68756319 (X.B.J.), +44 (0)115 9514115 (G.Z.C.); E-mail: xbjin@whu.edu.cn (X.B.J.), george.chen@nottingham.ac.uk (G.Z.C.).

Abstract

Abstract Image

Electrochemical reduction of a solid TiO2−ZrO2 mixture (molar ratio = 1:1) to the TiZr alloys in a consolidated porous structure was studied by constant cell voltage electrolysis in molten CaCl2 at 900 °C. For the first time, and surprisingly, it was found that tuning the α- and β-phases in the TiZr alloys could be easily realized by controlling the electrolysis time or, specifically, the oxygen content in the alloys. Oxygen acted as a phase-transition inhibitor from the high-temperature β-TiZr to the low-temperature α-TiZr, leading to metastable β-TiZr or (α+β)-TiZr as the product at room temperature. However, if the oxygen content decreased to <1100 ppm, only α-TiZr was collected, even when the electrolytic alloy was directly quenched in water. The consolidated porous (α+β)-TiZr alloys possessed elastic moduli in the range of 20−40 GPa, matching closely to that of natural bone (10−30 GPa). They also exhibited excellent corrosion resistance in the Ringer solution. These novel findings promise a simple, one-step, low-energy, and environmentally friendly electrochemical process for the production of β-phase containing TiZr alloys as medical implant materials without any added expensive and/or bio-incompatible elements.

Tools

SciFinder Links

SciFinder subscribers:  Click to sign in | Not a SciFinder subscriber? Learn more at www.cas.org

Explore by:


History

  • Published In Issue November 10, 2009
  • Article ASAPOctober 19, 2009
  • Received: July 09, 2009
    Revised: September 12, 2009

Recommend & Share

Related Content

Other ACS content by these authors: